The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Contemporary state-of-the-art PCI with functional and imaging concepts: forethoughts on the FAME 3 trial

EuroIntervention 2019;15:e219-e221. DOI: 10.4244/EIJV15I3A40

1. Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
As compared with bare metal stents, the use of drug-eluting stents (DES) has been associated with a significant reduction of angiographic and clinical restenosis and has become the default device in the contemporary practice of percutaneous coronary intervention (PCI). However, despite a remarkable improvement in PCI efficacy with DES, coronary artery bypass grafting (CABG) is still the preferred revascularisation strategy for patients with multivessel coronary artery disease (CAD), particularly those with diabetes and higher anatomic complexity1. Over the last decade, advances in DES technology, technical refinement, and adjunctive antithrombotic therapy have led to progressively improved PCI outcomes for complex CAD. ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Cardiac surgery in the time of TAVR: swan song or rebirth?